Endra Life Sciences Inc Expected To Post A Loss Of $2.00 A Share: Earnings Preview

ENDRA Life Sciences

20/08/2024 21:04

* ENDRA Life Sciences Inc  NDRA.OQ   NDRA.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 22 for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for ENDRA Life Sciences Inc
is for
a loss of $2.00 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts had risen by
about 74.1%
in the last three months. ​
    * Wall Street's median 12-month price target for ENDRA Life
Sciences Inc is $400.00​, above​ its last closing price
of $0.03. ​​​

This summary was machine generated August 20 at 20:04 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)